Introduction. Data were obtained on the difference in the quantitative and specific composition of intestinal microbiota bacteria in practically healthy individuals with subclinical invasions by pathogenic intestinal protozoa Lamblia intestinalis, Blastocystis hominis. Сhanges in bacterial composition were shown to have characterological features and species-specific «targets» of intestinal microbiota destruction. 
 Material and methods. Bacteriological and parasitological research methods were used. For a comparative analysis of quantitative and specific changes in the symbiotic microflora, there were formed two groups: “Yes” and “No” for each type of pathogenic protozoa, bacteriological indicators were ranked by quantitative content — CFU “0–103”, CFU “103–10max”, CFU “10max”. Statistical differences in research results were determined by the Chi-square calculation method. 
 Results. Antagonistic activity of unicellular protozoa in relation to the symbiotic bacterial intestinal microflora in the examined population groups has a different degree of severity depending on the type of invasion. Parasitic pathogens were shown to inhibit up to 40% of the quantitative and 50% of the species composition of the intestinal microflora and are an aggressive biogenic factor in the destruction of biota. There are no limitations of the study. 
 Limitations. The studies had no methodological or administrative restrictions.
 Conclusion. For the first time, significant statistical material has confirmed that asymptomatic parasitosis is a strong biogenic determinant of the development of destructive changes in the integral structure of the symbiotic microflora and the formation of a subclinical form of dysbiosis in an “almost healthy contingent” of the population. The asymptomatic carriage of Blastocysts spp. was found to have a more pronounced antagonistic effect on the bacterial composition of the intestinal microbiota than the presence of L. intestinalis, Blastocysts spp., form intestinal dysbiosis more aggressively, which indicates a greater pathogenic potential of B. hominis in the formation of intestinal pathology in humans.